SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-20-007590
Filing Date
2020-06-18
Accepted
2020-06-18 08:15:39
Documents
13
Period of Report
2020-06-17
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K imgn-20200618x8k.htm   iXBRL 8-K 52341
2 EX-10.1 imgn-20200617xex10d1.htm EX-10.1 25490
  Complete submission text file 0001558370-20-007590.txt   202951

Data Files

Seq Description Document Type Size
3 EX-101.SCH imgn-20200618.xsd EX-101.SCH 3039
4 EX-101.LAB imgn-20200618_lab.xml EX-101.LAB 16755
5 EX-101.PRE imgn-20200618_pre.xml EX-101.PRE 9902
12 EXTRACTED XBRL INSTANCE DOCUMENT imgn-20200618x8k_htm.xml XML 4646
Mailing Address 830 WINTER ST WALTHAM MA 02451
Business Address 830 WINTER ST WALTHAM MA 02451 (781)895-0600
ImmunoGen, Inc. (Filer) CIK: 0000855654 (see all company filings)

IRS No.: 042726691 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-17999 | Film No.: 20971278
SIC: 2834 Pharmaceutical Preparations